Acquiring Company
Boston Scientific
Acquired Company
Bolt Medical
Description
Boston Scientific has completed its acquisition of Bolt Medical following FDA clearance for Bolt's IVL technology. The acquisition aims to enhance Boston Scientific's cardiovascular portfolio. Originally announced in January, the purchase could reach up to $664 million. This acquisition is expected to advance treatment options for coronary and peripheral diseases.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed